Skip to main content

Table 1 Clinical and Demographic characteristics of subjects involved in the study with respect to number of individuals, age of diagnosis, duration of disease, genotype and antibody number.

From: Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes

Variable

AbN

AbP

T1D

Total number

117

19

82

Age (years)

15.1

14.5

15.8

   75%ile

22.0

28.5

20.1

   90%ile

37.0

37.0

36.0

Age range

(0.8–48.6)

(0.6–44.0)

(0.9–43.7)

Age of Diagnosis (years)

  

8.8 (0.8–41.2)

Duration of T1D (years)

  

6.2 (0–41.0)

Age: n (percent)

   

<20 years

86 (73.51)

14 (73.68)

60 (73.17)

>20 years

31 (26.49)

5 (26.32)

22 (26.83)

Sex: n (percent)

   

Male

53 (45.30)

9 (47.37)

50 (60.97)

Female

64 (54.70)

10 (52.63)

32 (39.03)

Genotype: n (percent)*

   

0201/0201

8 (6.84)

0 (0.00)

13 (15.85)

0302/0302

12 (10.26)

4 (21.05)

6 (7.32)

0201/0302

31 (26.50)

5 (26.32)

38 (46.34)

0201/x

21 (17.95)

3 (15.79)

10 (12.20)

0302/x

23 (19.66)

4 (21.05)

11 (13.41)

x/x

18 (15.38)

2 (10.53)

3 (3.66)

  1. Age, age of diagnosis and duration of disease is presented as means (range).
  2. *Genotyping information was not available on one AbP, one T1D and 4 AbN individual(s).
  3. Sex and genotype are presented as number of individuals of individuals (n). Values presented in parenthesis are percentage of total.